Both obese and anorexic women have low levels of 'feel good' neurosteroid

November 10, 2017, University of Illinois at Chicago

Women at opposite extremes of the weight spectrum have low levels of the neuroactive steroid allopregnanolone, according to new research published in the journal Neuropsychopharmacology.

Previous research has linked low levels of allopregnanolone—known to scientists as "allo"—to depression and anxiety, which are common mood disorders associated with anorexia nervosa and obesity.

Allo is a metabolite of the , one of the two major female hormones (the other being estrogen). Allo binds to receptors for the neurotransmitter gamma-aminobutyric acid (GABA) in the brain. These receptors are also the targets of anti-anxiety drugs such as benzodiazepines. Allo works by enhancing the signal produced when GABA binds to its receptor, generally producing a positive mood and feelings of well-being.

More than 50 percent of with anorexia nervosa have depression or anxiety, and 43 percent of adults who are obese have depression.

Low levels of allo have been linked to depression and anxiety in numerous previous studies, including people with depression and post-traumatic stress disorder. But the chemical—and its impact on mood—has not been measured in anorexic or obese women.

"We are beginning to see more and more evidence that low allo levels are tightly linked to depression, anxiety, and other mood disorders," said Graziano Pinna, associate professor of psychiatry in the University of Illinois at Chicago College of Medicine and an author on the paper. "To see that women with anorexia nervosa and obesity have low levels adds to the picture that the role of allo is under-recognized in mood disorders."

Pinna's colleagues, led by Dr. Karen Miller, professor of medicine at Harvard Medical School, recruited 12 women with anorexia nervosa and amenorrhea (stopped having their menstrual periods) whose body mass indices were less than 18.5; 12 normal-weight women with BMIs between 19 and 24; and 12 obese women with BMIs at 25 or higher. None of the women had received a diagnosis of depression or ever took antidepressants. The average age of the participants was 26 years old.

Participants completed questionnaires to assess for depression and anxiety and had blood drawn. Blood measurements of allo and other hormones were performed by Pinna's lab at the UIC. The lab had previously developed a novel, highly sensitive method technology to detect sex hormones and their metabolites. Pinna's lab is one of only three in the United States performing these measurements, which use gas chromatography and mass spectrometry to pick up extremely small levels of these chemicals in blood serum, saliva and brain tissue.

The researchers found that in women with anorexia nervosa and in obese women, blood levels of allo were 50 percent lower than they were in women with normal BMIs, and women who were clinically obese had allo levels approximately 60 percent lower than women with normal weights.

The researchers also found that levels of allo in all participants correlated with the severity of their depression and anxiety symptoms as measured by the questionnaires. Participants with lower levels of allo had greater severity of depression symptoms.

Progesterone levels were similarly low across all groups, suggesting that the decrease in allo in participants with anorexia nervosa and obesity may have been caused by improper functioning of enzymes responsible for the metabolism of into allo.

"Women with anorexia nervosa had low progesterone because they were amenorrheic, and the other two groups also had low progesterone levels because their blood was taken in the follicular phase when progesterone is naturally low," said Pinna. "That we found that had lower allo levels than normal weight participants adds to growing evidence that this steroid is involved in depression and anxiety regardless of how much progesterone is available to begin with."

Pinna believes that the enzymes that convert progesterone into allo may not be working properly, causing decreases in allo that lead to . "Drugs that increase the efficacy of these enzymes may be useful in helping to boost allo levels," he said. "But more research is needed to figure out exactly the deficit in the metabolism of progesterone into allo so that precision medicines using allo as a biomarker can be developed."

"Depression is an incredibly prevalent problem, especially in women, and also particularly at the extremes of the weight spectrum," said Miller. "The hope is that a greater understanding of mechanisms contributing to these disorders—including abnormalities in the regulation of hormones and their neuroactive metabolites—may lead to new targeted therapies in the future."

Pinna is leading preclinical studies of drugs designed to boost allo levels using several pharmacological strategies. These drugs have had promising effects in mouse models of PTSD and .

Explore further: High amounts of the hormone leptin are linked to decreased depression

More information: Laura E Dichtel et al, Neuroactive Steroids and Affective Symptoms in Women Across the Weight Spectrum, Neuropsychopharmacology (2017). DOI: 10.1038/npp.2017.269

Related Stories

High amounts of the hormone leptin are linked to decreased depression

June 6, 2011
Women who have higher levels of the appetite-controlling hormone leptin have fewer symptoms of depression, and this apparent inverse relationship is not related to body mass index (BMI), a new study finds. On Monday the results ...

Low levels of 'anti-anxiety' hormone linked to postpartum depression

March 14, 2017
In a small-scale study of women with previously diagnosed mood disorders, Johns Hopkins researchers report that lower levels of the hormone allopregnanolone in the second trimester of pregnancy were associated with an increased ...

Study reveals potential new treatment for postpartum smokers

October 12, 2017
Women who took replacement progesterone after giving birth had decreased cravings to smoke and were more likely to stay off cigarettes, according to a new Yale study that assessed the use of progesterone as a treatment for ...

Socialising difficulty in anorexia to guide treatment

August 14, 2014
In their investigation of eating disorders and interpersonal problems, researchers have found anorexia nervosa patients have significantly greater difficulties with socialising and assertiveness than those with bulimia nervosa, ...

Donor epstein-barr serostatus influences GVHD after allo-HSCT

April 19, 2016
(HealthDay)—Donor Epstein-Barr virus (EBV) serostatus influences incidence of graft-versus-host disease (GVHD) in patients with acute leukemia undergoing allogeneic hematopoietic stem-cell transplantation (allo-HSCT), according ...

Recommended for you

Brainwaves show how exercising to music bends your mind

February 18, 2018
Headphones are a standard sight in gyms and we've long known research shows listening to tunes can be a game-changer for your run or workout.

Link between hallucinations and dopamine not such a mystery, finds study

February 16, 2018
Researchers at Columbia University Irving Medical Center (CUIMC) and New York State Psychiatric Institute (NYSPI) found that people with schizophrenia who experience auditory hallucinations tend to hear what they expect, ...

People find comfort listening to the same songs over and over, study finds

February 16, 2018
With the frequency that some people play their favorite song, it's a good thing vinyl records aren't used often because they might wear out.

Ketamine found to reduce bursting in brain area reducing depression quickly

February 15, 2018
A team of researchers at Zhejiang University in China has found that the drug ketamine reduces neuronal bursting in the lateral habenula (LHb) brain region, reducing symptoms of depression in rodent models. In their paper ...

What predicts the quality of children's friendships? Study shows cognition, emotion together play

February 15, 2018
Whether children think their peers' intentions are benign or hostile, and how those children experience and express their own emotions, may influence the quality of their friendships, according to a new study from the University ...

Evidence shows pets can help people with mental health problems

February 15, 2018
The study of 17 research papers by academics at the Universities of Manchester, Southampton and Liverpool, concludes that pets can help people manage their long-term mental health conditions.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.